Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   


Term:Troxyca ER
go back to main search page
Accession:CHEBI:134679 term browser browse the term
Definition:A mixture composed of naltrexone hydrochloride and oxycodone hydrochloride (trade name Troxyca ER) that is specifically used for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Synonyms:related_synonym: Naltrexone hydrochloride and oxycodone hydrochloride;   Naltrexone hydrochloride mixture with oxycodone hydrochloride;   Naltrexone/oxycodone;   Oxycodone hydrochloride/naltrexone hydrochloride
 xref: CAS:850636-71-4 "ChemIDplus";   PMID:17685875 "Europe PMC";   PMID:25724154 "Europe PMC";   PMID:26011742 "Europe PMC"

show annotations for term's descendants       view all columns           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19654
    chemical entity 19652
      chemical substance 10721
        mixture 9926
          Troxyca ER 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19654
    subatomic particle 19650
      composite particle 19650
        hadron 19650
          baryon 19650
            nucleon 19650
              atomic nucleus 19650
                atom 19650
                  main group element atom 19531
                    main group molecular entity 19531
                      s-block molecular entity 19314
                        hydrogen molecular entity 19303
                          hydrides 18231
                            inorganic hydride 17095
                              pnictogen hydride 17053
                                nitrogen hydride 16874
                                  ammonium 8202
                                    ammonium ion derivative 8197
                                      naltrexone(1+) 0
                                        naltrexone hydrochloride 0
                                          Troxyca ER 0
paths to the root


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.